Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphom...
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models
About this item
Full title
Author / Creator
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States) , Frost, Sofia H L , Frayo, Shani L , Miller, Brian W , Orozco, Johnnie J , Booth, Garrett C , Hylarides, Mark D , Lin, Yukang , Green, Damian J , Gopal, Ajay K , Pagel, John M , Bäck, Tom A , Fisher, Darrell R and Press, Oliver W
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively delivering high doses of radiotherapy to tumor cells while minimizing exposure to surrounding tissues. Yttrium-90 (90Y) and lutetium-177 (177Lu) are two of the most promising beta-particle emitting radionuclides used for radioimmunotherapy, which despite having similar chem...
Alternative Titles
Full title
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1664460141
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1664460141
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0120561
